Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Director departure

GENOCEA BIOSCIENCES, INC. (GNCA) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/13/2022 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
06/13/2022 EFFECT Form EFFECT - Notice of Effectiveness:
06/13/2022 EFFECT Form EFFECT - Notice of Effectiveness:
06/09/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/09/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
06/08/2022 EFFECT Form EFFECT - Notice of Effectiveness:
06/03/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/03/2022 POS AM Form POS AM - Post-Effective amendments for registration statement:
06/03/2022 4 Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 1,355 shares @ $0.06, valued at $81.3
06/03/2022 4 Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 1,578 shares @ $0.06, valued at $94.7
06/03/2022 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 4,023 shares @ $0.06, valued at $241.4
06/02/2022 25 Form 25 - Notification of the removal from listing and registration of matured, redeemed or retired securities:
06/02/2022 4 SUMER JACQUELYN L (CHIEF LEGAL & COMPLIANCE OFF) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 2,500 shares @ $0.0601, valued at $150.3
06/02/2022 4 Clark William D (President and CEO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 117,244 shares @ $0.0617, valued at $7.2k
06/01/2022 4 Siber George (Director) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 20,425 shares @ $0.0653, valued at $1.3k
06/01/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
05/27/2022 SC 13D/A New Enterprise Associates 16, L.P. has filed a Schedule 13D for Genocea Biosciences, Inc.
05/26/2022 4 Walker Paul Edward (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Sonsini Peter W. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 SANDELL SCOTT D (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 New Enterprise Associates 16, L.P. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Makhzoumi Mohamad (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Florence Anthony A. Jr. (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Chang Carmen (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Behbahani Ali (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 BASKETT FOREST (10% Owner) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 5,931,843 shares @ $0.0654, valued at $387.9k
Sold 4,445,093 shares @ $0.0816, valued at $362.7k
05/26/2022 4 Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 16,525 shares @ $0.0881, valued at $1.5k
05/26/2022 4 Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 24,407 shares @ $0.0765, valued at $1.9k
05/24/2022 8-K Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Departure of Directors o...
04/29/2022 10-K/A Annual Report for the period ended December 31, 2021 [amend]
04/28/2022 8-K Cost Associated with Exit or Disposal Activities, Regulation FD Disclosure, Financial Statements and Exhibits &nbs...
Docs: "Genocea Initiates Restructuring and Announces Plan to Explore Strategic Alternatives"
04/05/2022 4 Flechtner Jessica Baker (Chief Scientific Officer) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 1,212 shares @ $1.25, valued at $1.5k
04/05/2022 4 Duvall Diantha (CFO) has filed a Form 4 on GENOCEA BIOSCIENCES, INC.
Txns: Sold 963 shares @ $1.25, valued at $1.2k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy